Zillion Pharmachem Ltd Stock Analysis

BSE: 524476 | NSE: ZILONPHARM | Pharmaceuticals & Drugs |

BSE Share Price
Not Listed

DeciZen - Make an Informed Decision on Zillion Pharmachem

M-Cap below 100cr DeciZen not available

Zillion Pharmachem Price Chart

P/E Ratio (SA) :
Market Cap :
0 Cr.
52-wk low :
0
52-wk high :
0
Bole Toh?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Zillion Pharmachem:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Information and data for this Company is currently unavailable.
We assure our users that information and data for the company will be available soon.

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Latest Financials - Zillion Pharmachem Ltd.

Standalone Consolidated
TTM EPS (₹) - -
TTM Sales (₹ Cr.) - -
BVPS (₹.) - -
Reserves (₹ Cr.) - -
P/BV - -
PE - -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) 0.50 / 140.00
Market Cap (₹ Cr.) -
Equity (₹ Cr.) -
Face Value (₹) -
Industry PE -

Management X-Ray of Zillion Pharmachem :

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Zillion Pharmachem

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

News

About Zillion Pharmachem Ltd

Zillion Pharmachem was incorporated on Aprril 24, 1992. It was promoted by Amit Shah, Bina Shah and Prafulchandra Barot. ZPL manufactures bulk drugs such as antendol, nifedipine, chloro pheniramine, trimethoprim, propanolol HCl and formulations such as ointments, injectables, syrups, capsules, tablets. It markets products under the brand names Zillion and Zee.

It entered into collaboration with Cuba Pharma Havana, Cuba, for products like Hepatitis B Surface Antigen vaccine, Streptokines, Facdermin cream, Meningocolol vaccine B & C, AIDS testing kits, and monoclonal antibiotics. ZPL has export orders worth Rs. 8.5 cr on hand. Export orders amounting to full capacity utilisation have been received from Dubai, Saudi Arabia, Indonesia, Singapore, Thailand, etc

The scrip of the company is suspended for trading since November 30, 2007.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now